Aprotinin Inhibits Protease-Dependent Platelet Aggregation and Thrombosis

This publication has 18 references indexed in Scilit:

• Clinical Inhibition of the Seven-Transmembrane Thrombin Receptor (PAR1) by Intravenous Aprotinin During Cardiothoracic Surgery
  Circulation, 2004
• Protection against thrombosis in mice lacking PAR3
  Blood, 2002
• The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
  The Lancet, 1999
• Aprotinin attenuates platelet accumulation in ischaemia???reperfusion-injured porcine skeletal muscle
  Blood Coagulation & Fibrinolysis, 1999
• New Variant of Human Tissue Plasminogen Activator (TPA) With Enhanced Efficacy and Lower Incidence of Bleeding Compared With Recombinant Human TPA
  Circulation, 1995
• Aprotinin
  Drugs, 1995
• Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality
  The Annals of Thoracic Surgery, 1995
• Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding
  The Annals of Thoracic Surgery, 1994
• Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation.
  Circulation Research, 1986